1. Home
  2. STKE vs MDAI Comparison

STKE vs MDAI Comparison

Compare STKE & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STKE

Sol Strategies Inc.

N/A

Current Price

$1.15

Market Cap

38.3M

Sector

N/A

ML Signal

N/A

MDAI

Spectral AI Inc.

N/A

Current Price

$1.65

Market Cap

39.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STKE
MDAI
Founded
2002
2013
Country
Canada
United States
Employees
N/A
78
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.3M
39.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STKE
MDAI
Price
$1.15
$1.65
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.25
AVG Volume (30 Days)
265.9K
518.3K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$552.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.07
$1.04
52 Week High
$7.75
$3.21

Technical Indicators

Market Signals
Indicator
STKE
MDAI
Relative Strength Index (RSI) 36.94 60.04
Support Level N/A $1.48
Resistance Level $1.65 $1.76
Average True Range (ATR) 0.18 0.12
MACD -0.03 0.04
Stochastic Oscillator 9.09 79.13

Price Performance

Historical Comparison
STKE
MDAI

About STKE Sol Strategies Inc.

Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: